-transparent.png){kind=logo}
Fifty patients with acute pelvic inflammatory disease were treated with Alphacillin (Pivampicillin Hcl). The total daily dose consisted of 1050mg, given in three divided doses. Treatment was continued for six days. Full bacteriological investigations were performed. Therapy was continued so long as the condition of the patient improved. In case of failure change to other antibiotics or surgery were considered. The clinical response to Alphacillin was considered successful in 92% of patients. A significant observation in the trial was the low rate of residual pelvic pathology especially in patients with Acute/Chronic pelvic infection. The drug was found to be free from complications or any serious side effects. Mild epigastric discomfort was noticed in only 3 patients.
E S Grech, and
E M Mutale, and
N Bathirunatham
December 1977,
East African medical journal,
E S Grech, and
E M Mutale, and
N Bathirunatham
June 1976,
West African journal of pharmacology and drug research,
E S Grech, and
E M Mutale, and
N Bathirunatham
June 1976,
West African journal of pharmacology and drug research,
E S Grech, and
E M Mutale, and
N Bathirunatham
February 1974,
The British journal of venereal diseases,
E S Grech, and
E M Mutale, and
N Bathirunatham
May 1981,
The British journal of clinical practice,
E S Grech, and
E M Mutale, and
N Bathirunatham
June 1975,
AMB : revista da Associacao Medica Brasileira,
E S Grech, and
E M Mutale, and
N Bathirunatham
September 1972,
Munchener medizinische Wochenschrift (1950),
E S Grech, and
E M Mutale, and
N Bathirunatham
January 1979,
Godisen zbornik na Medicinskiot fakultet vo Skopje,
E S Grech, and
E M Mutale, and
N Bathirunatham
January 1973,
Chemotherapy,
E S Grech, and
E M Mutale, and
N Bathirunatham
January 1986,
Scandinavian journal of infectious diseases,
